Can One App Help Stem the Tide of Opioid Abuse?

2018-12-13 14:58:39 Omed

Digital health solutions could be the most viable means of curbing the opioid abuse epidemic. FDA contributed to the support of this belief earlier this week, when it gave a nod to Pear Therapeutics’ mobile medical app. The solution, called reSET-O, is used to help those with opioid use disorder stay in recovery programs.

The Boston, MA-based company said the reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional, in conjunction with treatment that includes buprenorphine and contingency management.

“As part of our efforts to address the misuse and abuse of opioids, we’re especially focused on new tools and therapies that can help more people with opioid use disorder successfully treat their addiction,” Scott Gittlieb, MD, FDA commissioner said in a release. “Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in contributing to these treatment efforts.”

Nearly 170 patients were evaluated in a 12-week clinical trial of a desktop version of reSET-O. Data from the trial showed a statistically significant increase in retention in a treatment program for 12 weeks for the patients who used the desktop computer version of the reSET-O program compared to those who did not. In the trial, patients who used the desktop computer version of reSET-O had an overall retention rate through the end of 12 weeks of treatment of 82.4% compared with 68.45% overall retention rate for patients who did not.

FDA used the data to make a clearance determination for reSET-O.

This isn’t Pear Therapeutics’ first rodeo with FDA. In September of last year the company received a nod to market reSET, a solution that it said was the first app given approval to treat substance abuse. The app was cleared for use as an adjuvant to standard outpatient therapy to treat patients with substance use disorder for stimulants, cannabis, cocaine, and alcohol.

 

閱讀全文
  • 相關廠商

    亞力士電腦機械股份有限公司南科分公司

    ARDENTA德國雅典娜牙體系統利用牙體掃描器及CAD/CAM集牙體加工機能快速地製造有型態的PMMA及臘型,氧化鋯和樹酯也可應用在植牙Implant Bridge,模型,支架等模組.應用高階電腦數位化..創造出牙技的數位優勢及經濟效益.


    台灣創新生醫股份有限公司

    Taiwan Innovative Biomedical Co.,Ltd(TIB) persists in the ambition to be the most outstanding medical device supplier, aims for the provision of the most satisfactory medical quality to patients and the decrease in the risk of medical treatment for physicians, and fulfills our obligation as being a good citizen to create a beautiful future for ourselves and the society! 台灣創新生物醫學股份有限公司(TIB),堅持成為最優秀的醫療器械供應商,力求為患者提供最滿意的醫療質量,降低醫師的醫療風險,使病患減少磨合次數、減少牙齦發黑、降低軟組織過敏性反應、省時、安全、降低就診次數,通過ISO、GMP、FDA國際認證,TIB為全球唯一符合國際醫療法規牙科膺復件醫材廠,讓患者更加安心使用!


    喜樂醫療器材股份有限公司

    喜樂醫材(JMD)是一高度研發導向並致力於提升醫療器材品質之醫療器材公司。JMD於2009年設廠進駐於台灣南部科學園區,開發並生產一系列創新的骨科與牙科用的醫療器材產品,包含一般型及非使用抗生素的抗菌型高誘骨、高骨置換率之Ezechbone®系列的鈣基骨泥及骨粒產品,並搭配其使用之微創手術用高孔隙骨粒及骨泥傳輸系統(jBranch™)。其它創新技術如微創擴骨系統、高強度/低彈性模數之牙科鑄造及植入型Ti-Mo合金、可臨床調整形狀的顱顏面迷你骨板、新一代人工牙根等,也將陸續問世。